Skip to main content

Table 1 Demographic characteristics and operative data

From: Acute kidney injury after infant cardiac surgery: a comparison of pRIFLE, KDIGO, and pROCK definitions

Variables

Non-AKI (n = 228)

AKI by pRIFLE (n = 185)

AKI by KDIGO (n = 160)

AKI by pROCK (n = 77)

Age (day)

202 (139–311)

178 (122–258)

182 (121–260)

156 (105–237)

Male gender

118 (51.8%)

95 (51.4%)

82 (51.2%)

44 (57.1%)

RACHS category ≥ 3

39 (17.1%)

32 (17.3%)

29 (18.1%)

13 (16.9%)

2003Weight (kg)

7.06 ± 1.60

6.81 ± 1.68

6.77 ± 1.70

6.47 ± 1.76

Body length (cm)

67.73 ± 7.23

65.95 ± 7.58

65.86 ± 7.72

64.13 ± 7.67

Premature delivery

27 (11.8%)

21 (11.4%)

21 (13.1%)

12 (15.6%)

Birth weight (kg)

3.14 ± 0.59

3.14 ± 0.64

3.11 ± 0.65

3.10 ± 0.69

PAH

103 (45.2%)

82 (44.3%)

72 (45.0%)

41 (53.2%)

LVEF (%)

70 (67–73)

70 (65–73)

69 (65–73)

70 (65–73)

LVEDD (mm)

26.72 ± 7.12

27.02 ± 6.17

26.81 ± 6.29

25.88 ± 6.88

WBC (109/L)

9.42 ± 2.90

8.80 ± 2.46

8.79 ± 2.53

8.78 ± 2.46

Hemoglobin (g/L)

117.59 ± 20.02

112.90 ± 15.56

112.97 ± 16.13

113.66 ± 19.12

Albumin (g/L)

42.02 ± 3.30

41.90 ± 3.15

41.98 ± 3.26

41.69 ± 3.59

AST (IU/L)

23 (18–34)

23 (17–38)

23 (17–37)

24 (17–37)

ALT (IU/L)

51 (43–61)

49 (39–62)

48 (38–61)

47 (38–59)

TBIL (umol/L)

5.85 (3.96–8.65)

6.50 (4.49–9.30)

6.81 (4.34–9.82)

6.75 (4.76–12.05)

DBIL (umol/L)

1.43 (0.92–2.38)

1.80 (1.18–2.76)

1.93 (1.21–3.11)

2.35 (1.40–3.46)

SCr (umol/L)

29.75 ± 8.48

23.96 ± 6.29

23.52 ± 6.19

23.67 ± 6.42

Cystatin-C (mg/L)

1.12 ± 0.24

1.11 ± 0.21

1.10 ± 0.21

1.14 ± 0.21

BUN (umol/L)

3.35 (2.28–4.64)

2.86 (2.11–4.36)

2.98 (2.16–4.48)

3.14 (2.14–4.58)

CPB duration (min)

83 (66–106)

85 (61–106)

83 (61–105)

90 (71–118)

ACC duration (min)

54 (43–77)

55 (41–76)

54 (41–76)

56 (45–80)

Nadir temperature (℃)

30.79 ± 1.48

30.97 ± 1.46

31.01 ± 1.51

30.86 ± 1.73

  1. AKI Acute kidney injury, pRIFLE Pediatric-modified Risk, Injury, Failure, Loss, and End-Stage, KDIGO Kidney Disease: Improving Global Outcomes, pROCK pediatric reference change value optimized for AKI in children, RACHS Risk Adjustment for Congenital Heart Surgery, PAH Pulmonary arterial hypertension, LVEF left ventricular ejection fraction, LVEDD left ventricular end-diastolic dimension, WBC White blood cell, TBIL Total bilirubin; DBIL direct bilirubin, AST Aspartate aminotransferase, ALT Alanine aminotransferase, SCr, serum creatinine, BUN Blood urea nitrogen (umol/L), CPB Cardiopulmonary bypass, ACC Aortic cross-clamping